References
- Avery, R., Kenkel, D., Lillard, D., & Alan M. (2007a). Regulating advertisements: The case of smoking cessation products. Journal of Regulatory Economics, 31(2), 185-208. https://doi.org/10.1007/s11149-006-9021-9
- Avery, R., Kenkel, D., Lillard, D., & Alan M. (2007b). Private profits and public health: Does advertising smoking cessation products encourage smokers to quit? Journal of Political Economy, 115(3), 447-481. https://doi.org/10.1086/520065
- Calfee, J. E. (2002). Public policy issues in direct-toconsumer advertising of prescription drugs. Journal of Public Policy & Marketing, 21(Fall), 174-193. https://doi.org/10.1509/jppm.21.2.174.17580
- Creyer, E. H., Hrsistodoulakis, I., & Cole, C. A. (2001). Changing a drug from Rx to OTC status: the consumer behavior and public policy implications of switch drugs. Journal of Product and Brand Management, 10(1), 52-64. https://doi.org/10.1108/10610420110382821
- Donohue, J. (2006). Direct-to-consumer advertising of prescription drugs: Does it add to the overuse and inappropriate use of prescription drugs or alleviate under-use? International Journal of Pharmaceutical Medicine, 20(1), 17-24. https://doi.org/10.2165/00124363-200620010-00002
- Hoek, J., Gendall, P., Rapson, L., & Louviere, J. (2011). Information accessibility and consumers' knowledge of prescription drug benefits and risks. Journal of Consumer Affairs, 45(2), 248-274. https://doi.org/10.1111/j.1745-6606.2011.01202.x
- Food and Drug Administration. (2002). Claritin approval marks significant shift in Rx-to-OTC switches. The Food & Drug Letter, Issue No. 666.
- Frosch, D. L, Grande, D., Tam, D. M., & Kravitz, R. L. (2010). A decade of controversy: Balancing policy with evidence in the regulation of prescription drug advertising. American Journal of Public Health, 100(1), 24-32. https://doi.org/10.2105/AJPH.2008.153767
- Kaphingst, K. A., & DeJong, W. (2004). The educational potential of direct-to-consumer prescription drug advertising. Health Affairs, 23(4), 143-150. https://doi.org/10.1377/hlthaff.23.4.143
- Kelly, P. (2004). Perspective: DTC advertising's benefits far outweigh its imperfections. Health Affairs, w4, 246-248.
- Korea Food and Drug Administration (2011). Press release: KFDA's perspective on Rx-to-OTC switch, from http://www.kfda.go.kr/index.kfda?mid=56&pageNo=8&seq=15808&cmd=v
- Lexchin, J. (1999). Direct-to-consumer advertising: Impact on patient expectations regarding disease management. Disease Management and Health Outcomes, 5(May), 273-283. https://doi.org/10.2165/00115677-199905050-00004
- Ling, D., Berndt, E., & Kyle, M. (2002). Deregulating direct to consumer marketing of drugs: Effects on prescription and over-the-counter product sales. The Journal of Law and Economics, 45(2), 691-723. https://doi.org/10.1086/368004
- Meek, C. (2001). Direct-to-Consumer Advertising of Prescription Medicines: A Review of International Policy and Evidence. London: Royal Pharmaceutical Society of Great Britain.
- Morris, L., Ruffner, M., & Klimberg, R. (1985). Warning disclosures for prescription drugs, Journal of Advertising Research, 25(October-December), 25-32.
- Morris, L., Brinberg, D., Klimberge, R., Rivera, C., & Millstein, L. (1986). The attitudes of consumers toward direct advertising of prescription drugs. Public Health Report, 101(1), 82-89.
- Myers, S. D., Royne, M. B., & Deitz, G. D. (2011). Direct-to-consumer advertising: exposure, behavior, and policy implications. Journal of Public Policy & Marketing, 30(1), 110-118. https://doi.org/10.1509/jppm.30.1.110
- Toop, L., Richards, D., Dowell, T., Tilyard, M., Fraser, T., & Arroll, B. (2003). DTCA in New Zealand - Report to Minister of Health Supporting the Ban on DTCA.
Cited by
- eWOM, revisit intention, destination trust and gender vol.31, 2017, https://doi.org/10.1016/j.jhtm.2016.12.005
- Cross-border mobility and social networks: Laotians seeking medical treatment along the Thai border vol.124, 2015, https://doi.org/10.1016/j.socscimed.2014.10.022
- Understanding medical tourists: Word-of-mouth and viral marketing as potent marketing tools vol.34, 2013, https://doi.org/10.1016/j.tourman.2012.04.010
- Impact of online WOM on destination trust and intention to travel: A medical tourism perspective vol.5, pp.3, 2016, https://doi.org/10.1016/j.jdmm.2015.12.005
- The Impact of Direct-to-Consumer Advertising of Prescription Medications on Healthy Lifestyle vol.50, pp.4, 2011, https://doi.org/10.6115/khea.2012.50.4.103